Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
247.6 EUR | +0.81% |
|
-.--% | -.--% |
06-25 | Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval | MT |
06-25 | Roche: approval of Ocrevus SC in Europe | CF |